1. Home
  2. PRAX vs QCRH Comparison

PRAX vs QCRH Comparison

Compare PRAX & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • QCRH
  • Stock Information
  • Founded
  • PRAX 2015
  • QCRH 1993
  • Country
  • PRAX United States
  • QCRH United States
  • Employees
  • PRAX N/A
  • QCRH N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • QCRH Major Banks
  • Sector
  • PRAX Health Care
  • QCRH Finance
  • Exchange
  • PRAX Nasdaq
  • QCRH Nasdaq
  • Market Cap
  • PRAX 1.5B
  • QCRH 1.4B
  • IPO Year
  • PRAX 2020
  • QCRH 1993
  • Fundamental
  • Price
  • PRAX $71.55
  • QCRH $84.46
  • Analyst Decision
  • PRAX Strong Buy
  • QCRH Buy
  • Analyst Count
  • PRAX 9
  • QCRH 3
  • Target Price
  • PRAX $146.33
  • QCRH $76.00
  • AVG Volume (30 Days)
  • PRAX 315.5K
  • QCRH 65.2K
  • Earning Date
  • PRAX 11-06-2024
  • QCRH 01-21-2025
  • Dividend Yield
  • PRAX N/A
  • QCRH 0.28%
  • EPS Growth
  • PRAX N/A
  • QCRH 6.88
  • EPS
  • PRAX N/A
  • QCRH 6.88
  • Revenue
  • PRAX $1,605,000.00
  • QCRH $341,805,000.00
  • Revenue This Year
  • PRAX N/A
  • QCRH N/A
  • Revenue Next Year
  • PRAX N/A
  • QCRH $10.78
  • P/E Ratio
  • PRAX N/A
  • QCRH $12.54
  • Revenue Growth
  • PRAX N/A
  • QCRH 5.07
  • 52 Week Low
  • PRAX $16.08
  • QCRH $53.22
  • 52 Week High
  • PRAX $86.93
  • QCRH $96.08
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 50.90
  • QCRH 41.23
  • Support Level
  • PRAX $70.03
  • QCRH $86.11
  • Resistance Level
  • PRAX $73.49
  • QCRH $91.49
  • Average True Range (ATR)
  • PRAX 4.10
  • QCRH 1.84
  • MACD
  • PRAX -0.17
  • QCRH -0.94
  • Stochastic Oscillator
  • PRAX 48.89
  • QCRH 0.40

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.

Share on Social Networks: